GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

被引：0
|
作者：
Juris J. Meier
机构：
[1] St Josef-Hospital,Division of Diabetology
[2] Ruhr-University Bochum,undefined
来源：
Nature Reviews Endocrinology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this Review, the possibilities for utilizing GLP-1 receptor agonists in individualized treatment for type 2 diabetes mellitus are discussed. The currently available compounds are evaluated in terms of their efficacy, duration of action and adverse effects. The feasibility of selecting a treatment option on the basis of an individual's clinical parameters and requirements is also touched upon.
引用
收藏
页码：728 / 742
页数：14
相关论文
共 50 条
  • [21] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
  • [22] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [23] Factors Predicting GLP-1 Receptor Agonists Efficacy in Type 2 Diabetes Mellitus Treatment: A Retrospective Observational Study
    Duvnjak, Lea
    Blaslov, Kristina
    DIABETES, 2016, 65 : A572 - A572
  • [24] Evaluating the Response to GLP-1 Agonists in Veterans with Type 2 Diabetes Mellitus
    Begley, Brett A.
    Desouza, Cyrus
    Shivaswamy, Vijay
    Samson, Kaeli
    Silverman, Emily
    DIABETES, 2021, 70
  • [25] Treatment of Type 2 Diabetes mellitus (T2DM): Can GLP-1 Receptor Agonists fill in the gaps?
    Sharma, Smriti
    Bhatia, Vinayak
    CHEMICAL BIOLOGY LETTERS, 2020, 7 (04): : 215 - 224
  • [26] Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus
    Owens, D. R.
    Monnier, L.
    Bolli, G. B.
    DIABETES & METABOLISM, 2013, 39 (06) : 485 - 496
  • [27] Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel
    Knop, Filip K.
    Holst, Jens J.
    Vilsboll, Tina
    IDRUGS, 2009, 12 (08) : 503 - 513
  • [28] Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
    Nauck, Michael A.
    Meier, Juris J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R211 - R234
  • [29] Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus
    McBrayer, Dominic N.
    Tal-Gan, Yftah
    DRUG DEVELOPMENT RESEARCH, 2017, 78 (06) : 292 - 299
  • [30] GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
    Neumiller, Joshua J.
    Alicic, Radica Z.
    Tuttle, Katherine R.
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 386 - 398
12345